Delivery of Quality Care:
Process, Outcomes and Reporting

SATURDAY – FEBRUARY 16

1:30 pm - 3:00 pm

The Medical Directors Conference this year's BMT Tandem Meetings will provide an up-to-the-minute look at how the BMT community is responding to the new federal law that requires the reporting of allogeneic stem cell transplant outcomes to the Stem Cell Transplant Outcomes Database (SCTOD). 

The requirements for outcome analysis and reporting will be considered within the context of treatment process validation and quality improvement. 

The SCTOD – An Early-Phase Progress Report

■ Mary Horowitz, MD, MS, Center for International Blood and Marrow Transplant Research, Milwaukee

The SCTOD – With Your Help, We Can Get It Right

■ Roy B. Jones, MD, PhD, M. D. Anderson Cancer Research Center, Houston

Process that Supports Good Outcomes – Is Your Quality Plan Ready?

■ C. Fred LeMaistre, MD, Texas Transplant Institute, San Antonio